What's next for Genentech employees?

Imagine you're a Genentech worker in San Diego. Since Roche and Genentech first signed their partnership deal in the 1990s, you've enjoyed a relatively hands-off approach that's allowed independent research to thrive. In fact, Roche's affiliation with Genentech is regarded as the gold standard of what a Big Pharma's relationship with a small biotech should be. Article

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.